.

NEWS AND VIEWS THAT IMPACT LIMITED CONSTITUTIONAL GOVERNMENT

"There is danger from all men. The only maxim of a free government ought to be to trust no man living with
power to endanger the public liberty." - - - - John Adams

Thursday, February 13, 2025

Ozempic Users Face Blindness Side Effect



A series of new reports has raised concerns over potential links between popular weight loss medications and vision loss. 

Several studies indicate that drugs such as Ozempic and Mounjaro, which contain semaglutide and tirzepatide, may contribute to conditions leading to severe and possibly permanent blindness.

Researchers recently highlighted nine cases in the United States where individuals experienced vision loss after using these drugs. 

In one documented instance, a woman experienced blindness in her left eye the morning after receiving her first injection of semaglutide. Despite stopping the medication, she had to resume it due to her diabetes, only to lose vision in her right eye shortly after.



Another case involved a woman taking semaglutide for a year. She developed vision issues because of retinal blood vessel damage. Additionally, a man suffered eye bleeding linked to tirzepatide, though he was advised to continue the medication due to insufficient evidence of the drug causing his condition

Experts suggest that rapid reductions in blood sugar levels associated with these weight loss drugs might harm eye blood vessels, resulting in vision loss.

Despite these findings, causation has not been definitively proved. The American Academy of Ophthalmology has advised patients experiencing vision problems while on semaglutide to consult their physicians, but has not advised against the drug’s use overall.

Ozempic is manufactured by the Danish company Novo Nordisk, which has previously used race to try and get U.S. taxpayers to foot the bill for its obesity drugs through programs like Medicare.

TheNationalPulse.com




No comments: